Low-Molecular-Weight Methylcellulose-Based Thermo-reversible Gel/Pluronic Micelle Combination System for Local and Sustained Docetaxel Delivery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jang Kyoung | - |
dc.contributor.author | Won, Young-Wook | - |
dc.contributor.author | Lim, Kwang Suk | - |
dc.contributor.author | Kim, Yong-Hee | - |
dc.date.accessioned | 2022-07-16T16:49:01Z | - |
dc.date.available | 2022-07-16T16:49:01Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2012-02 | - |
dc.identifier.issn | 0724-8741 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/166352 | - |
dc.description.abstract | To develop low-molecular-weight methylcellulose (LMw MC)-based gel/Pluronic F127 micelle combination system for local and sustained delivery of docetaxel (DTX). LMw MC and Pluronic F127 were used to formulate an injectable thermo-reversible gel/micelle combination system containing DTX. The DTX-loaded combination system was characterized and its therapeutic efficacy evaluated in a subcutaneous tumor model. Mixtures of LMw MC, AS, and Pluronic F127 formed gel at similar to 15-40A degrees C depending on AS concentration. The combination system released DTX for > 30 days with a biphasic and sustained release pattern, and DTX stability was maintained during release. The combination system significantly enhanced anti-cancer effects of DTX and prolonged survival of the model mouse in comparison with free DTX. The LMw MC gel/Pluronic F127 micelle combination system constitutes a promising tool for reducing tumor size and eradicating remaining tumor cells before and after surgery. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER/PLENUM PUBLISHERS | - |
dc.title | Low-Molecular-Weight Methylcellulose-Based Thermo-reversible Gel/Pluronic Micelle Combination System for Local and Sustained Docetaxel Delivery | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Yong-Hee | - |
dc.identifier.doi | 10.1007/s11095-011-0581-8 | - |
dc.identifier.scopusid | 2-s2.0-84860850040 | - |
dc.identifier.wosid | 000299506700017 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICAL RESEARCH, v.29, no.2, pp.525 - 534 | - |
dc.relation.isPartOf | PHARMACEUTICAL RESEARCH | - |
dc.citation.title | PHARMACEUTICAL RESEARCH | - |
dc.citation.volume | 29 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 525 | - |
dc.citation.endPage | 534 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | HYDROLYZED METHYL CELLULOSE | - |
dc.subject.keywordPlus | BLOCK-COPOLYMER MICELLES | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | POLYMERIC MICELLES | - |
dc.subject.keywordPlus | PACLITAXEL | - |
dc.subject.keywordPlus | NANOPARTICLES | - |
dc.subject.keywordPlus | HYDROGELS | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | FORMULATIONS | - |
dc.subject.keywordAuthor | cancer therapy | - |
dc.subject.keywordAuthor | docetaxel | - |
dc.subject.keywordAuthor | drug delivery | - |
dc.subject.keywordAuthor | gel/micelle combination system | - |
dc.subject.keywordAuthor | methylcellulose | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs11095-011-0581-8 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.